These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5862667)

  • 1. The effects of some cancer chemotherapy agents on the sulphydryl levels of normal rat tissues.
    Calcutt G
    Br J Cancer; 1965 Dec; 19(4):883-93. PubMed ID: 5862667
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of combined cytoxic agents on the bone marrow].
    Maisin H
    C R Seances Soc Biol Fil; 1966; 160(8):1740-4. PubMed ID: 4227904
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative cytotoxic properties of ifosfamide and cyclophosphamide in rat solid tumor and normal tissues.
    Tew KD
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):24-7. PubMed ID: 7163812
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies with cyclophosphamide labeled with phosphorus-32: nucleic acid alkylation and its effect on DNA synthesis in rat tumor and normal tissues.
    Tew KD; Taylor DM
    J Natl Cancer Inst; 1977 May; 58(5):1413-9. PubMed ID: 857031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and metabolism of two sphingomyelins in rat tissues.
    Minari O; Tsubono H; Akiyama M; Sakagami T
    J Biochem; 1968 Aug; 64(2):275-8. PubMed ID: 5708331
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biochemistry of antileukemic drugs].
    Bollag W
    Schweiz Med Wochenschr; 1970 Feb; 100(7):310-4. PubMed ID: 4908606
    [No Abstract]   [Full Text] [Related]  

  • 7. Haemopoietic spleen colonies in rats treated with cytotoxic drugs.
    Dunn CD; Elson LA
    Rev Fr Etud Clin Biol; 1969 Jan; 14(1):57-9. PubMed ID: 5784820
    [No Abstract]   [Full Text] [Related]  

  • 8. The metabolism of 9-beta-d-xylofuranosyl-6-mecaptopurine in normal and neoplastic tissues.
    Sato K; LePage GA; Kimball AP
    Cancer Res; 1966 Apr; 26(4):741-7. PubMed ID: 5934906
    [No Abstract]   [Full Text] [Related]  

  • 9. Some effects of chlorambucil on the uptake and utilization of sulphydryl-containing compounds by tumour cells.
    Harrap KR; Riches PG; Jackson RC; Smith CA
    Biochem Pharmacol; 1973 Nov; 22(22):2881-9. PubMed ID: 4761557
    [No Abstract]   [Full Text] [Related]  

  • 10. Human bone marrow sulphydryl levels.
    Calcutt G; Bromley A
    Br J Haematol; 1968 Mar; 14(3):273-7. PubMed ID: 5694409
    [No Abstract]   [Full Text] [Related]  

  • 11. Disposition of treosulfan and its active monoepoxide in a bone marrow, liver, lungs, brain, and muscle: Studies in a rat model with clinical relevance.
    Romański M; Kasprzyk A; Walczak M; Ziółkowska A; Główka F
    Eur J Pharm Sci; 2017 Nov; 109():616-623. PubMed ID: 28916482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mode of action of chlorambucil. Initial metabolic studies using carbon 14 isotope labeling. Rheumatological implications of their results].
    Sauvezie B; Rampon S; Bussière JL; Godenèche D; Chollet P; Plagne R
    Rev Rhum Mal Osteoartic; 1975 May; 42(5):337-44. PubMed ID: 1145086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE BIOCHEMICAL BASIS FOR THE DIFFERENTIAL SENSITIVITY OF INTESTINAL MUCOSA AND BONE MARROW TO 6-THIOGUANINE.
    MARCHESI SL; SARTORELLI AC
    Cancer Res; 1963 Dec; 23():1769-73. PubMed ID: 14082871
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced growth of transplanted tumours after treatment with cytotoxic agents.
    Calcutt G
    Biochem Pharmacol; 1968 Aug; 17(8):1742-4. PubMed ID: 4970520
    [No Abstract]   [Full Text] [Related]  

  • 15. Mercury distribution studies involving complexes of low-molecular weight thiols and methylmercury.
    Balthrop JE; Wade JL; Braddon-Galloway S
    Bull Environ Contam Toxicol; 1986 Dec; 37(6):890-8. PubMed ID: 3790762
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of the association of 6-mercaptopurine-chlorambucil and 6-mercaptopurine-myleran on the growth of Galliera sarcoma in the rat].
    BRAMBILLA G; BALDINI L
    Boll Soc Ital Biol Sper; 1960 Jun; 36():587-90. PubMed ID: 13803814
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of age and experimentally-induced disease on the tolerance of cytostatically-active materials in mice.
    Lemmel EM; Motycka K; Soucek J; Nouza K
    Arzneimittelforschung; 1967 Feb; 17(2):142-5. PubMed ID: 4173310
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetic aids to proper chemotherapeutic scheduling: labeled nucleoside incorporation studies in vivo.
    Young RC
    Cancer Treat Rep; 1976 Dec; 60(12):1947-58. PubMed ID: 1026349
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of H3-mexamine in the mouse body and liver cells].
    Pavlova LM; Sverdlov AG; Grachev SA; Bagiian GA
    Radiobiologiia; 1975 MAR-APR; 15(2):306-8. PubMed ID: 1057217
    [No Abstract]   [Full Text] [Related]  

  • 20. Transplantable mouse plasma cell tumors in experimental chemotherapy.
    Teller MN; Abraham D; Bowie M; Carbone PP
    J Natl Cancer Inst; 1969 Jul; 43(1):123-31. PubMed ID: 5816022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.